These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 12843396)

  • 1. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
    Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiology. Pods invade infected bladders.
    Ferber D
    Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host subversion by formation of intracellular bacterial communities in the urinary tract.
    Anderson GG; Martin SM; Hultgren SJ
    Microbes Infect; 2004 Oct; 6(12):1094-101. PubMed ID: 15380779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Mulvey MA; Lopez-Boado YS; Wilson CL; Roth R; Parks WC; Heuser J; Hultgren SJ
    Science; 1998 Nov; 282(5393):1494-7. PubMed ID: 9822381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
    Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
    Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
    Schilling JD; Mulvey MA; Hultgren SJ
    J Infect Dis; 2001 Mar; 183 Suppl 1():S36-40. PubMed ID: 11171011
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
    J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
    Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
    J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili.
    Wright KJ; Seed PC; Hultgren SJ
    Cell Microbiol; 2007 Sep; 9(9):2230-41. PubMed ID: 17490405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms.
    Parsons CL
    Urol Clin North Am; 1986 Nov; 13(4):563-8. PubMed ID: 2877517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toll-like receptor that prevents infection by uropathogenic bacteria.
    Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
    Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
    Mulvey MA; Schilling JD; Martinez JJ; Hultgren SJ
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8829-35. PubMed ID: 10922042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface properties of Escherichia coli strains responsible for urinary infections.
    Romano Carratelli C; Nuzzo I; Galdiero M
    Microbiologica; 1987 Jan; 10(1):55-61. PubMed ID: 2883558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA; Schilling JD; Hultgren SJ
    Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle.
    Min G; Stolz M; Zhou G; Liang F; Sebbel P; Stoffler D; Glockshuber R; Sun TT; Aebi U; Kong XP
    J Mol Biol; 2002 Apr; 317(5):697-706. PubMed ID: 11955018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression.
    Yin X; Chen L; Liu Y; Yang J; Ma C; Yao Z; Yang L; Wei L; Li M
    Biochem Biophys Res Commun; 2010 Jun; 397(2):232-8. PubMed ID: 20546703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic interactions between host and pathogen during acute urinary tract infections.
    Schilling JD; Mulvey MA; Hultgren SJ
    Urology; 2001 Jun; 57(6 Suppl 1):56-61. PubMed ID: 11378051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.